Donna Rill, Chief Technology Officer
Professional Overview
Donna Rill is an accomplished Chief Technology Officer with over 30 years of experience in the biotechnology and pharmaceutical industries. She has a proven track record of driving innovation and leading the development of cutting-edge cell and gene therapy technologies. Rill's expertise spans a wide range of areas, including translational research, manufacturing, and regulatory compliance.
Experience Summary
Current Role
As the Chief Technology Officer at Triumvira Immunologics USA, Inc., Rill is responsible for overseeing the company's technological development and innovation efforts. She leads a team of talented scientists and engineers, guiding the implementation of advanced cell and gene therapy platforms to address unmet medical needs. Under her leadership, Triumvira has made significant strides in advancing its proprietary T-cell antigen coupler (TAC) technology, which holds promise for the treatment of various cancers.
Career Progression
Prior to her role at Triumvira, Rill served as the Vice President of Manufacturing at Cell Medica, where she was instrumental in the scale-up and commercialization of the company's cellular immunotherapy products. Before that, she held the position of Chief Development Officer at Opexa Therapeutics, where she spearheaded the development and clinical testing of novel immunotherapies for autoimmune diseases.
Rill's earlier career includes roles as the Laboratory Director of Translational Research at Baylor College of Medicine's Center for Cell & Gene Therapy, and as an Associate Scientist and Laboratory Manager of the Cell & Gene Therapy Labs at St. Jude Children's Research Hospital. Her expertise in translational research and laboratory management has been instrumental in driving advancements in the field of cell and gene therapy.
Academic Background
Donna Rill holds a Bachelor of Science degree in Medical Technology from the University of Tennessee Health Science Center. Her academic achievements and specialized training have positioned her as a leading expert in the field of biotechnology and immunology.
Areas of Expertise
- Cell and gene therapy technology development
- Translational research and clinical development
- Immunology and autoimmune disease treatment
- Biomanufacturing and quality control
- Regulatory compliance and strategic planning
- Cross-functional team leadership and collaboration
Professional Impact
Throughout her career, Rill has made significant contributions to the advancement of cell and gene therapy technologies. She has authored numerous peer-reviewed publications and presented her research at prestigious industry conferences. Rill's work has led to the development of innovative therapies that have the potential to transform the treatment of various diseases, including cancer and autoimmune disorders.
Conclusion
With her extensive experience, deep technical expertise, and visionary leadership, Donna Rill is poised to continue driving transformative advancements in the field of biotechnology. As the Chief Technology Officer at Triumvira Immunologics USA, Inc., she is well-equipped to guide the company's technology development and contribute to the ongoing progress in cell and gene therapy.
